|1.||Strasburger, C J: 2 articles (12/2005 - 12/2001)|
|2.||Madsbad, Sten: 2 articles (12/2004 - 01/2004)|
|3.||Haugaard, Steen B: 2 articles (12/2004 - 01/2004)|
|4.||Andersen, Ove: 2 articles (12/2004 - 01/2004)|
|5.||Hansen, Birgitte R: 2 articles (12/2004 - 01/2004)|
|6.||Iversen, Johan: 2 articles (12/2004 - 01/2004)|
|7.||Andersen, Ulrik B: 2 articles (12/2004 - 01/2004)|
|8.||Orskov, Hans: 2 articles (12/2004 - 01/2004)|
|9.||Flyvbjerg, Allan: 2 articles (12/2004 - 01/2004)|
|10.||Raynaud-Simon, A: 2 articles (01/2003 - 05/2002)|
|1.||Body Weight (Weight, Body)
05/01/2001 - "Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels."
03/01/1993 - "Analysis of variance revealed a significant negative effect of Type 1 diabetes on serum levels of the growth hormone-binding protein and of insulin-like growth factor I. In the diabetic patients, serum levels of the growth hormone-binding protein were positively related to body mass index and to insulin dose per kg body weight, and were not influenced by pubertal stage, gender, or plasma levels of haemoglobin A1c. "
02/01/2003 - "Body weight (P < 0.003), lean body mass (P < 0.006), D-xylose absorption (P < 0.02), insulin-like growth factor 1 (P < 0.002), and insulin-like growth factor binding protein 3 (P < 0.002) increased, whereas uptake of GH binding protein decreased (P < 0.01), without any major adverse effect. "
09/01/2003 - "Relative to the control group, women of the intervention group showed a significant reduction of body weight, waist circumference, fasting serum levels of testosterone, C peptide, glucose, and insulin area after glucose tolerance test, and a significant increase of serum levels of sex hormone-binding globulin, IGFBP-1, -2, and growth hormone-binding protein. "
07/01/2005 - "Growth hormone binding protein and acid labile subunit levels in the assessment of acromegaly treatment."
01/01/1997 - "In the medical treatment of acromegaly different factors are influential; among these the impact on growth hormone binding protein (GHBP) has not been clarified. "
05/01/1995 - "Dynamic changes of growth hormone-binding protein concentrations in normal men and patients with acromegaly: effects of short-term fasting."
10/01/1992 - "We conclude that growth hormone binding protein levels are down regulated in acromegaly, indicating an important role for GH in the regulation of this protein."
01/01/1992 - "Growth-hormone-binding protein in patients with acromegaly."
|3.||Laron Syndrome (Syndrome, Laron)
01/01/1998 - "We have previously described two families (H and M) with GH binding protein-positive Laron Syndrome (LS), proposed to have one or more post GHR signaling defects. "
12/01/1997 - "A minority of patients with Laron syndrome have normal serum GH binding protein (GHBP), indicating that the defect is elsewhere than in the extracellular domain of the GH receptor. "
05/01/1997 - "Girls with Laron syndrome having positive growth hormone binding protein (GHBP) are less retarded in height than those lacking GHBP."
08/01/1995 - "Patients with idiopathic short stature have decreased serum levels of the GH receptor-related GH-binding protein (GHBP), and low GHBP levels are associated with complete GH insensitivity (Laron) syndrome. "
06/01/1994 - "In Laron syndrome, growth retardation is caused by GH resistance due to GH receptor (GH-R) defects, which are associated in most cases with absent or low serum concentrations of the GH-R-related GH-binding protein (GHBP). "
08/01/1991 - "We wished in this study to define the serum GH-binding protein status of a family with Laron-type dwarfism. "
03/20/1993 - "In a case of GH-resistant dwarfism, in which GH-binding protein activity was markedly reduced, the patient's GH secretion to GRF as high as 51 ng/ml did not induce any increment of FFA levels. "
10/20/1992 - "Interestingly, the high affinity GH binding protein (GHBP) is identical with the extracellular domain of GH receptor and is absent in patients with Laron-type dwarfism, suggesting that serum GHBP might serve as a marker for the GH receptor in tissue. "
11/15/1991 - "Given the sequence homology between the extracellular domain of the GHR and a soluble GH-binding protein (GH-BP), it is remarkable that GH-BP binding activity is absent from the serum of patients with Laron-type GH insensitivity, a hereditary form of severe dwarfism. "
10/20/1991 - "[A case of dwarfism with severely reduced activity of growth hormone-binding protein]."
12/01/1997 - "The serum concentration of the high-affinity growth hormone-binding protein (GHBP) is increased in obesity but the mechanisms are poorly understood. "
04/01/1996 - "GH-binding protein (GHBP) is increased in obesity. "
01/01/2000 - "This may contribute to the normal/high serum-IGF-I and high GH-binding protein levels in obesity. "
01/01/2000 - "Although GH hyposecretion in obesity may decrease the generation of IGF-I in each adipocyte, increased amounts of IGF-I and GH-binding protein could be secreted from the excessively enlarged amounts of adipose tissue. "
04/01/1996 - "Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss."
|3.||Insulin-Like Growth Factor Binding Protein 1
|5.||Sex Hormone-Binding Globulin
|7.||Insulin-Like Growth Factor I (IGF-1)
|8.||Growth Hormone (Somatotropin)
|9.||Insulin-Like Growth Factor Binding Proteins
|10.||Human Growth Hormone (Saizen)